Tag: cancer

The Endocrine Society, the world’s oldest and largest organization devoted to hormone research and the clinical practice of endocrinology, has officially announced that its members have elected Joy Wu, MD, PhD, as the Society’s President for the 2027–2028 term. Dr. Wu, a distinguished physician-scientist currently serving at the Stanford University School of Medicine, will begin…

The medical landscape has been fundamentally reshaped over the last several years by the emergence of glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of pharmaceuticals that has transitioned from specialized diabetic treatments to a global cultural and healthcare phenomenon. Often recognized by brand names such as Ozempic and Wegovy, these medications have permeated the public…

The Endocrine Society has officially confirmed that its premier annual meeting, ENDO 2026, will be held in Chicago, Illinois, from June 13 to June 16, 2026. This significant global gathering is expected to transform the city into the epicenter of hormone research and clinical practice, bringing together more than 7,200 clinicians, researchers, and medical professionals…

The United States medical research landscape is currently facing a period of significant fiscal instability as Congress struggles to finalize a full-year spending bill for the 2026 fiscal year (FY 2026). At the center of this budgetary deadlock is the National Institutes of Health (NIH), the primary federal agency responsible for biomedical and public health…

The commencement of 2026 marks a pivotal moment for the global medical community as the Endocrine Society introduces its newest cohort of Laureate Award winners, alongside groundbreaking research in thyroid pathology and the launch of a sophisticated digital infrastructure for metabolic research. These developments, highlighted in the January 2026 edition of Endocrine News, underscore the…

The study challenges traditional clinical thresholds that focus primarily on full-blown gestational diabetes mellitus (GDM). Instead, it highlights a spectrum of risk associated with gestational glucose intolerance (GGI), where even a single abnormal glucose reading during prenatal testing can correlate with significant weight issues in the child a decade or more later. This finding suggests…

NYU Langone Health has officially announced the appointment of Marcus D. Goncalves, MD, PhD, as the new director of the Holman Division of Endocrinology, Diabetes, and Metabolism. Dr. Goncalves, a distinguished physician-scientist and a nationally recognized leader in the field of metabolic research, succeeds Ira J. Goldberg, MD, who has served as the division’s director…

This landmark study, recently published in The Journal of Clinical Endocrinology & Metabolism, reveals a breakthrough in cardiovascular risk assessment for individuals living with HIV. Researchers from Fudan University and the Shanghai Institute of Infectious Diseases have identified a specific set of biological markers in the blood that can predict the development of dangerous arterial…

The landscape of metabolic medicine underwent a significant transformation in early January 2026 as the 25 mg oral formulation of semaglutide, marketed under the brand name Wegovy, officially became available to patients across the United States. This launch follows a pivotal approval by the U.S. Food and Drug Administration (FDA), which cleared the once-daily tablet…

The United States Congress has finalized and passed a comprehensive funding bill for the Department of Health and Human Services (HHS) for the 2026 fiscal year, marking a significant milestone for the biomedical research community and patients nationwide. This legislative achievement follows an intensive year-long advocacy campaign led by the Endocrine Society and a coalition…